The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
The proposed project tests the efficacy of glutamate modulators in non-depressed individuals
with alcohol use disorder (AUD); the primary hypothesis is that the glutamate modulator being
tested reduces heavy drinking days compared to the active control. It also aims to
investigate, using a 2 by 2 factorial (2x2) design, the hypothesis that the effects of the
glutamate modulator are enhanced when combined with behavioral treatment.
Phase:
Phase 2
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)